APA(7版)引用形式

Latini, R., Staszewsky, L., Sun, J., Bethel, M., Disertori, M., Haffner, S., . . . McMurray, J. (2013). Incidence of atrial fibrillation in a population with impaired glucose tolerance: The contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.

Chicagoスタイル(17版)引用形式

Latini, R., et al. Incidence of Atrial Fibrillation in a Population with Impaired Glucose Tolerance: The Contribution of Glucose Metabolism and Other Risk Factors. A Post Hoc Analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research Trial. 2013.

MLA(9版)引用形式

Latini, R., et al. Incidence of Atrial Fibrillation in a Population with Impaired Glucose Tolerance: The Contribution of Glucose Metabolism and Other Risk Factors. A Post Hoc Analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research Trial. 2013.

警告: この引用は必ずしも正確ではありません.